Aspen launches novel ARV Combination: Set to further improve treatment options

Johannesburg: Aspen Pharmacare, South Africa’s leading JSE-listed pharmaceutical company, is pleased to announce the launch of EmdoltenTM, a Dolutegravir-based triple »

Aspen launches novel ARV Combination: Set to further improve treatment options

Johannesburg: Aspen Pharmacare, South Africa’s leading JSE-listed pharmaceutical company, is pleased to announce the launch of EmdoltenTM, a Dolutegravir-based triple »

 

We care for those in need

Our pledge to care for vulnerable citizens dates back to the early 2000s when we first signaled our commitment to »

news

We care for those in need

Our pledge to care for vulnerable citizens dates back to the early 2000s when we first signaled our commitment to »